Correspondence 0001104659-23-093950 from Cartica Acquisition Corp (CRTAF, CRTUF, CRTWF) (CIK 0001848437) (CRTAF)
Cartica Acquisition Corp (CRTAF, CRTUF, CRTWF) (CIK 0001848437)
Date: Aug. 21, 2023 · CIK: 0001848437 · Accession: 0001104659-23-093950
AI Filing Summary & Sentiment
File numbers found in text: 001-41198
Show Raw Text
CORRESP
1
filename1.htm
CARTICA ACQUISITION CORP
c/o Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
VIA EDGAR
August 21, 2023
U.S. Securities & Exchange Commission
Division of Corporation Finance
Office of Energy & Transportation
100 F Street, NE
Washington, D.C. 20549
Attn: Craig Arakawa
Re:
Cartica Acquisition Corp
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed March 31, 2023
File No. 001-41198
Dear Mr. Arakawa:
Cartica Acquisitions Corp
(the “Company,” “we,” “our” or “us”) hereby transmits the
Company’s response to the comment letter received from the staff (the “Staff”) of the U.S. Securities and Exchange
Commission, on August 17, 2023, regarding its Form 10-K for the Fiscal Year Ended December 31, 2022 filed on March 31, 2023.
For the Staff’s convenience,
we have repeated below the Staff’s comment in bold, and have followed the comment with the Company’s response.
Form 10-K for Fiscal Year Ended December 31, 2022
General
1. We note disclosures in your Definitive Proxy Statement filed on June 12, 2023 relating to the potential
risks of your initial business combination being subject to a review by the Committee on Foreign Investment in the United States. Please
include corresponding disclosure in future periodic reports.
The Company respectfully acknowledges the Staff’s comment
and advises the Staff that it has included a risk factor substantially in the form below in its Form 10-Q for Quarter Ended June 30, 2023
and will continue to include the risk factor in other appropriate future filings under the Securities Act of 1933, as amended and the
Securities Exchange Act of 1934, as amended.
We may not be able to complete
an initial business combination with certain potential target companies if a proposed transaction with the target company may be subject
to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.
Certain acquisitions or business combinations
may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations. In the event that
such regulatory approval or clearance is not obtained, or the review process is extended beyond the period of time that would permit an
initial business combination to be consummated with us, we may not be able to consummate a business combination with such target.
Among other things, the U.S. Federal
Communications Act prohibits foreign individuals, governments, and corporations from owning more than a specified percentage of the capital
stock of a broadcast, common carrier, or aeronautical radio station licensee. In addition, U.S. law currently restricts foreign ownership
of U.S. airlines. In the United States, certain mergers that may affect competition may require certain filings and review by the Department
of Justice and the Federal Trade Commission, and investments or acquisitions that may affect national security are subject to review by
the Committee on Foreign Investment in the United States (“CFIUS”). CFIUS is an interagency committee authorized to review
certain transactions involving foreign investment in the United States by foreign persons in order to determine the effect of such transactions
on the national security of the United States.
Outside the United States, laws or regulations
may affect our ability to consummate a business combination with potential target companies incorporated or having business operations
in jurisdiction where national security considerations, involvement in regulated industries (including telecommunications), or in businesses
relating to a country’s culture or heritage may be implicated.
U.S. and foreign regulators generally
have the power to deny the ability of the parties to consummate a transaction or to condition approval of a transaction on specified terms
and conditions, which may not be acceptable to us or a target. In such event, we may not be able to consummate a transaction with that
potential target.
As a result of these various
restrictions, the pool of potential targets with which we could complete an initial business combination may be limited and we may
be adversely affected in terms of competing with other SPACs that do not have similar ownership issues. Moreover, the process of
government review could be lengthy. Because we have only a limited time to complete our initial business combination, our failure to
obtain any required approvals within the requisite time period may require us to liquidate. If we liquidate, our public shareholders
may only receive $10.69 per share as of July 16, 2023, and our warrants will expire worthless. This will also cause you to lose any
potential investment opportunity in a target company and the chance of realizing future gains on your investment through any price
appreciation in the combined company.
****
We thank the Staff for its
review of the foregoing. If you have further comments, please feel free to contact our counsel, Wei Wang, Esq., at wwang@egsllp.com or
by telephone at (212) 370-1300.
Sincerely,
Cartica Acquisition Corp
By:
/s/ Suresh Guduru
Name:
Suresh Guduru
Title:
Chief Executive Officer
cc:
Wei Wang, Esq.
Ellenoff Grossman & Schole LLP